EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Characteristics of Patients with Myasthenia Gravis in the French Rare Disease Registry

Jean-Philippe Camdessanche iD, Andoni Echaniz-Laguna iD, Guilhem Solé iD, Cécile Blein, Mariana Ciumas, Claude Messiaen, Anne-Sophie Jannot iD, Shahram Attarian iD

European Journal of Neurology · 2026-04 · 33 (4)

DOI: 10.1111/ene.70604 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2026-04-22. Written by Jean-Philippe Camdessanche and 7 co-authors. Institution: Department of Neurology, Neuromuscular Disease Reference Centre, Hôpital Nord, University Hospital of Saint-Étienne, Euro-NMD, Saint-Étienne, France. Major MEDLINE topics: Myasthenia Gravis, Registries, Rare Diseases. 29 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Argenx, French Ministry of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The French National Rare Diseases Registry (BNDMR) was established in 2007 to ensure access to optimal care standards for all patients with rare diseases in dedicated reference centres. The objective of this retrospective cohort study was to describe patients with myasthenia gravis (MG) in the BNDMR.

Methods

All patients aged ≥ 18 years in the BNDMR with a confirmed diagnosis of MG visiting a reference centre at least once between 2007 and 2021 (inclusive) were included. Diagnosis was defined through ORPHA:589 or ORPHA:391490 disease codes. Patients were followed for ≥ 12 months until 31 December 2022 (or until death). Data were collected on demographics and disease history. Mortality was estimated using Kaplan–Meier survival analysis. Healthcare resource utilisation at the reference centre was documented.

Results

Overall, 3963 patients were analysed. Mean follow‐up duration was 6.1 ± 3.8 years. The median interval between diagnosis and inclusion was 3.8 months [IQR: 1.5–7.5] and the median age at symptom onset was 52.0 [IQR: 34.0–69.0] years. Survival probability was 82.7% at 10 years, and higher in women than men ( p < 0.001; logrank test). The mean interval between visits was 4.1 months. The mean number of overnight or day hospitalisations per patient was 2.6 ± 3.4 and the mean number of physician consultations per patient per year was 1.7 ± 1.1.

Conclusion

This national registry study provides reference data for patients in France with a confirmed diagnosis of MG. However, all patients with MG are still not managed in dedicated reference centres.

Subjects

MeSH terms (MEDLINE)

Myasthenia GravisRegistriesRare DiseasesHumansFemaleMaleFranceAdultMiddle AgedRetrospective StudiesAged

Author keywords

epidemiologyhealthcare resource utilisationmortalitymyasthenia gravispatient registry

Authors and institutions

  • Department of Neurology, Neuromuscular Disease Reference Centre, Hôpital Nord, University Hospital of Saint-Étienne, Euro-NMD, Saint-Étienne, France.
  • Department of Neurology, APHP, CHU de Bicêtre, INSERM U1195, Paris-Saclay University, Le Kremlin-Bicêtre, France.
  • Neuromuscular Reference Center AOC, Neurology and Neuromuscular Diseases Department, Pellegrin Hospital, Bordeaux University Hospitals, Bordeaux, France.
  • Argenx, Ghent, Belgium.
  • BNMDR, Paris, France.
  • Reference Centre for Neuromuscular Disease and ALS, Timone University Hospital, Aix-Marseille University, CHU Timone, Filnemus, Euro-NMD, Marseille, France.

ORCID profiles: Jean-Philippe Camdessanche, Andoni Echaniz-Laguna, Guilhem Solé, Anne-Sophie Jannot, Shahram Attarian

Funding

  • Argenx
  • French Ministry of Health

Cite

APA

Camdessanche, J. P., Echaniz-Laguna, A., Solé, G., Blein, C., Ciumas, M., Messiaen, C., Jannot, A. S., & Attarian, S. (2026). Characteristics of Patients with Myasthenia Gravis in the French Rare Disease Registry. European Journal of Neurology, 33(4). https://doi.org/10.1111/ene.70604

Vancouver

Camdessanche JP, Echaniz-Laguna A, Solé G, Blein C, Ciumas M, Messiaen C, et al. Characteristics of Patients with Myasthenia Gravis in the French Rare Disease Registry. European Journal of Neurology. 2026;33(4). doi:10.1111/ene.70604

BibTeX
@article{Camdessanche2026,
  author = {Camdessanche, Jean-Philippe and Echaniz-Laguna, Andoni and Solé, Guilhem and Blein, Cécile and Ciumas, Mariana and Messiaen, Claude and Jannot, Anne-Sophie and Attarian, Shahram},
  title = {Characteristics of Patients with Myasthenia Gravis in the French Rare Disease Registry},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {4},
  doi = {10.1111/ene.70604}
}
Start for free →